Antonio Gotto, MD, Cardiology, New York, NY, New York-Presbyterian Hospital

AntonioMGottoMD

Cardiology New York, NY

Professor of Medicine, Cornell University-Weill Medical College

Dr. Gotto is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gotto's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1966 - 1967
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Transitional Year, 1965 - 1966
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1965

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2022
  • TX State Medical License
    TX State Medical License 1972 - 2023
  • MD State Medical License
    MD State Medical License 1969 - 2000
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 1991
  • Elected Member The American Society for Clinical Investigation, 1971
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Association of Bempedoic Acid Administration with Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients with Hypercholesterolemia  
    Antonio M Gotto, Zhan Ye, JAMA Cardiology

Authored Content

  • ACC 2021: Updates in Treating DyslipidemiaJune 2021
  • Association of Bempedoic Acid Administration with Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients with HypercholesterolemiaJuly 2020
  • Association of Bempedoic Acid Administration with Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients with HypercholesterolemiaJuly 2020

Press Mentions

  • Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients
    Intensive Lipid-Lowering Slashes CVD in Elderly ACS PatientsJuly 19th, 2019
  • Higher Intensity Therapy with Simvastatin-Ezetimibe May Benefit Elderly Patients After ACS
    Higher Intensity Therapy with Simvastatin-Ezetimibe May Benefit Elderly Patients After ACSJuly 18th, 2019
  • ZETIA’S Established “Adverse Effects” (Still) Ignored by Prescribing Docs: Its Re-Branding & Deadly Consequences. Patients, Beware! Commentary by Adina Kutnicki
    ZETIA’S Established “Adverse Effects” (Still) Ignored by Prescribing Docs: Its Re-Branding & Deadly Consequences. Patients, Beware! Commentary by Adina KutnickiNovember 24th, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations